Literature DB >> 12684159

Requirements for growing tissue-engineered vascular grafts.

Shannon L Mitchell1, Laura E Niklason.   

Abstract

Small diameter (< 6 mm) vascular grafts are in large demand for coronary and peripheral bypass procedures. Although synthetic grafts have been developed, tissue-based vascular grafts that can better mimic native vessels will likely yield superior results. The success of a tissue-based graft depends on its ability to meet several requirements. First, a graft must possess a confluent, adherent and quiescent endothelium to resist thrombosis in vivo. The mechanical behavior of the graft must mimic the mechanical properties of a native vessel. Hence, a graft must have a highly organized collagen matrix to impart tissue strength. Finally, a graft must contain an elastin network to provide compliance and recoil. Copyright 2003 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684159     DOI: 10.1016/s1054-8807(02)00183-7

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  43 in total

1.  Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy.

Authors:  Ingrid Garzón; Barbara Pérez-Köhler; Juan Garrido-Gómez; Victor Carriel; Renato Nieto-Aguilar; Miguel Angel Martín-Piedra; Natalio García-Honduvilla; Julia Buján; Antonio Campos; Miguel Alaminos
Journal:  Tissue Eng Part C Methods       Date:  2012-01-26       Impact factor: 3.056

2.  Enzymatic cross-linking of human recombinant elastin (HELP) as biomimetic approach in vascular tissue engineering.

Authors:  Sabrina Bozzini; Liliana Giuliano; Lina Altomare; Paola Petrini; Antonella Bandiera; Maria Teresa Conconi; Silvia Farè; Maria Cristina Tanzi
Journal:  J Mater Sci Mater Med       Date:  2011-10-13       Impact factor: 3.896

3.  A hybrid biomimetic nanomatrix composed of electrospun polycaprolactone and bioactive peptide amphiphiles for cardiovascular implants.

Authors:  Adinarayana Andukuri; Meenakshi Kushwaha; Ajay Tambralli; Joel M Anderson; Derrick R Dean; Joel L Berry; Young Doug Sohn; Young-Sup Yoon; Brigitta C Brott; Ho-Wook Jun
Journal:  Acta Biomater       Date:  2010-08-20       Impact factor: 8.947

Review 4.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

5.  Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineering mechanically robust and vasoreactive vascular media.

Authors:  Hao-Fan Peng; Jin Yu Liu; Stelios T Andreadis; Daniel D Swartz
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

6.  Shear stress and circumferential stretch by pulsatile flow direct vascular endothelial lineage commitment of mesenchymal stem cells in engineered blood vessels.

Authors:  Dong Hwa Kim; Su-Jin Heo; Yun Gyeong Kang; Ji Won Shin; So Hee Park; Jung-Woog Shin
Journal:  J Mater Sci Mater Med       Date:  2016-01-22       Impact factor: 3.896

7.  Mechanical properties and compositions of tissue engineered and native arteries.

Authors:  Shannon L M Dahl; Caroline Rhim; Ying C Song; Laura E Niklason
Journal:  Ann Biomed Eng       Date:  2007-01-06       Impact factor: 3.934

8.  Collagen- and gelatine-based films sealing vascular prostheses: evaluation of the degree of crosslinking for optimal blood impermeability.

Authors:  M Madaghiele; A Piccinno; M Saponaro; A Maffezzoli; A Sannino
Journal:  J Mater Sci Mater Med       Date:  2009-05-18       Impact factor: 3.896

9.  Highly Aligned Nanofibrous Scaffold Derived from Decellularized Human Fibroblasts.

Authors:  Qi Xing; Caleb Vogt; Kam W Leong; Feng Zhao
Journal:  Adv Funct Mater       Date:  2014-05-28       Impact factor: 18.808

10.  Porcine endothelial cells cocultured with smooth muscle cells became procoagulant in vitro.

Authors:  Zhengyu Pang; Laura E Niklason; George A Truskey
Journal:  Tissue Eng Part A       Date:  2010-06       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.